Geode Capital Management, LLC Natera, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,841,557 shares of NTRA stock, worth $199 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,841,557

Previous 1,771,062 3.98%

Holding current value

$199 Million

Previous $111 Million 51.82%

% of portfolio

0.02%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$59.21 - $92.9 $4.17 Million - $6.55 Million	70,495 Added 3.98%	1,841,557 $168 Million
Q4 2023 Feb 13, 2024	BUY	$37.55 - $62.64 $4.78 Million - $7.98 Million	127,393 Added 7.75%	1,771,062 $111 Million
Q3 2023 Nov 13, 2023	SELL	$43.4 - $62.52 $501,790 - $722,856	-11,562 Reduced 0.7%	1,643,669 $72.7 Million
Q2 2023 Aug 11, 2023	BUY	$47.08 - $55.16 $5.67 Million - $6.64 Million	120,423 Added 7.85%	1,655,231 $80.5 Million
Q1 2023 May 15, 2023	BUY	$36.57 - $58.29 $2.03 Million - $3.23 Million	55,432 Added 3.75%	1,534,808 $85.2 Million

Q4 2022 Feb 13, 2023	BUY	$34.17 - $47.91 $7.42 Million - $10.4 Million	217,067 Added 17.2%	1,479,376 $59.4 Million
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $3.45 Million - $5.29 Million	93,310 Added 7.98%	1,262,309 $55.3 Million
Q2 2022 Aug 12, 2022	BUY	$28.13 - $44.54 $385,774 - $610,821	13,714 Added 1.19%	1,168,999 $41.4 Million
Q1 2022 May 13, 2022	BUY	$30.32 - $91.33 $854,963 - $2.58 Million	28,198 Added 2.5%	1,155,285 $47 Million
Q4 2021 Feb 11, 2022	BUY	$86.26 - $119.0 $3.13 Million - $4.31 Million	36,243 Added 3.32%	1,127,087 $105 Million
Q3 2021 Nov 12, 2021	BUY	$100.17 - $126.36 $6.67 Million - $8.42 Million	66,619 Added 6.5%	1,090,844 $122 Million
Q2 2021 Aug 13, 2021	SELL	$86.05 - $119.72 $25.9 Million - $36 Million	-300,793 Reduced 22.7%	1,024,225 $116 Million
Q1 2021 May 12, 2021	BUY	$91.47 - $124.36 $8.47 Million - $11.5 Million	92,625 Added 7.52%	1,325,018 $135 Million
Q4 2020 Feb 12, 2021	BUY	$66.66 - $111.74 $8.92 Million - $15 Million	133,821 Added 12.18%	1,232,393 $123 Million
Q3 2020 Nov 13, 2020	BUY	$45.89 - $72.67 $2.41 Million - $3.82 Million	52,566 Added 5.03%	1,098,572 $79.4 Million
Q2 2020 Aug 13, 2020	BUY	$26.36 - $49.86 $1.61 Million - $3.05 Million	61,222 Added 6.22%	1,046,006 $52.2 Million
Q1 2020 May 14, 2020	BUY	$17.27 - $40.17 $1.18 Million - $2.74 Million	68,194 Added 7.44%	984,784 $29.4 Million
Q4 2019 Feb 13, 2020	BUY	$32.1 - $40.4 $2.87 Million - $3.62 Million	89,493 Added 10.82%	916,590 $30.9 Million
Q3 2019 Nov 12, 2019	BUY	$25.38 - $34.89 $329,203 - $452,558	12,971 Added 1.59%	827,097 $27.1 Million
Q2 2019 Aug 14, 2019	BUY	$17.75 - $27.58 $5.4 Million - $8.4 Million	304,401 Added 59.72%	814,126 $22.5 Million
Q1 2019 May 14, 2019	BUY	$11.34 - $20.62 $529,532 - $962,871	46,696 Added 10.08%	509,725 $10.5 Million
Q4 2018 Feb 13, 2019	BUY	$12.32 - $24.38 $329,818 - $652,676	26,771 Added 6.14%	463,029 $6.46 Million
Q3 2018 Nov 13, 2018	BUY	$18.82 - $28.96 $1.12 Million - $1.72 Million	59,263 Added 15.72%	436,258 $10.4 Million
Q2 2018 Aug 14, 2018	BUY	$8.79 - $19.98 $183,464 - $417,022	20,872 Added 5.86%	376,995 $7.09 Million
Q1 2018 May 15, 2018	BUY	$9.0 - $11.95 $29,457 - $39,112	3,273 Added 0.93%	356,123 $3.3 Million
Q4 2017 Feb 13, 2018	BUY	$8.99 - $14.31 $123,234 - $196,161	13,708 Added 4.04%	352,850 $3.17 Million
Q3 2017 Nov 14, 2017	BUY	$8.02 - $13.33 $649,876 - $1.08 Million	81,032 Added 31.39%	339,142 $4.37 Million
Q2 2017 Aug 14, 2017	BUY	N/A	258,110	258,110 $2.8 Million

Others Institutions Holding NTRA

# of Institutions

439

Shares Held

117M

Call Options Held

254K

Put Options Held

263K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $10.5B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Natera, Inc. Transaction History